A collaborative study with Harvard Medical School
For patients battling cancer, diabetes, or other chronic conditions, wound care isn’t just a medical necessity—it’s a daily struggle that affects dignity, comfort, and overall quality of life. Malignant fungating wounds, diabetic foot ulcers, pressure ulcers, and burns present unique challenges such as:
- Persistent pain that makes even gentle touch unbearable
- Embarrassing odor leading to social isolation
- Heavy exudate that damages the surrounding skin
- Wounds that resist traditional treatment approaches
- Infection and biofilm formation
These hidden challenges demand innovative solutions that go beyond conventional dressings.
MaxioCel: Not Just Another Wound Dressing
MaxioCel represents a breakthrough in wound care technology. Made from 100% chitosan with innovative Bioactive Microfibre Gelling (BMG®) technology, MaxioCel doesn’t just cover wounds—it actively creates an optimal healing environment.
The Unique Three-Pronged Approach of MaxioCel
- Accelerated Wound Healing
- BMG® technology promotes faster granulation and autolytic debridement (removal of slough & necrotic tissue).
- Odor Management
- Helps reduce odor by removing devitalized tissue and slough—restoring dignity for patients.
- Antimicrobial & Anti-Biofilm Action
- Positively charged MaxioCel fibers attract, disrupt, and kill bacteria, reducing infection risk.
Most importantly, the BMG® dressing remains in situ even during radiotherapy, ensuring uninterrupted wound management—something most traditional dressings cannot achieve.
Clinical Evidence: Malignant Fungating Wounds
A recent four-week clinical study with oncology patients demonstrated remarkable outcomes when MaxioCel was integrated into wound care protocols.
✅ Enhanced wound bed appearance through effective debridement
✅ Significant odor reduction, easing one of the most socially distressing symptoms
✅ Reduced pain levels, even in highly sensitive wounds
✅ Superior exudate management, preventing further skin breakdown
✅ Improved patient comfort & dignity during treatment
One notable case involved a patient who remained comfortable and odour-free throughout radiotherapy—a stage where most wound dressings fail due to compatibility issues.
Beyond Oncology: Versatility Across Chronic Wound Types
The benefits of MaxioCel extend far beyond oncology care, making it suitable for multiple chronic wound scenarios:
- Diabetic Foot Ulcers → Reduces infection risk with strong antimicrobial properties
- Pressure Ulcers → Provides comfort while maintaining moisture balance
- Burns → Offers a soothing, non-adherent texture to aid effective healing
- Post-Surgical & Chronic Wounds → Gentle, skin-friendly dressing suitable for diverse wound care situations
A Bright Future for Wound Care
We’re entering a new era of advanced wound management where clinical effectiveness and patient experience go hand in hand. MaxioCel sets a new benchmark by addressing exudate, pain, odor, and infections—while significantly reducing hospitalization time and treatment costs.
👉 If you’re facing complex wound challenges, don’t settle for traditional dressings.
Discover the healing power of MaxioCel with BMG® technology—and experience the difference.
